HAPI Student Wins SFS Global Impact Pitch Competition
May 6th, 2025
The M.S. Health and the Public Interest (HAPI) program heartily congratulates Jackson Hoffman on both representing the Graduate School at the annual CASE workshop and winning a first-place grant at…
Ukraine, “Single Biggest Loser?” Anya Hirschfeld ’24 on USAID Budget Cuts
April 22nd, 2025
Amid sweeping budget cuts, Ukraine has become the “single biggest loser” of USAID funding…and its healthcare workers are feeling the strain. Last week, Anya Hirschfeld (MS ‘24) published…
Application Deadline Extended to May 1st, 2025
April 2nd, 2025
Given the reduction in federal workforce, we recognize that career plans for both working professionals and graduating students may be changing. As such, we are pleased to extend our regular…
Fee Waivers and Flexible Deadlines Introduced for Those Impacted by Federal Workforce Reduction
March 12th, 2025
Georgetown’s Health and the Public Interest program values the impactful work of those in public service, and we recognize that federal government reductions in the workforce and other governmental…
Changing Cultural Norms: HAPI Alum Anya Hirschfeld Published in Think Global Health
February 27th, 2025
When [Peru] released its first dataset in 2015, the numbers painted a grim picture: IPV [intimate partner violence] rates nearly three times the global average and widespread femicide…Although…
RFK’ Jr.’s Immunity to Scientific Evidence is Dangerous: Co-Director Comments
February 13th, 2025
As a physician with a long career in alternative medicine and who opposes pharmaceutical marketing, you might think I have a lot in common with Robert F Kennedy Jr. You’d be wrong. Dr. Adriane…
A Hard Look at Prescribing: Program Co-Director Comments on New Opioid Study
February 13th, 2025
This February, Program Co-Director Adriane Fugh-Berman and her colleague, Judy Butler, authored an article breaking down a new study on opioid prescribing and use disorders. According to the…
History Repeating? Program Co-Director Comments on “Non-Addictive” Pain Pill in The Washington Post
January 17th, 2025
This week, Dr. Adriane Fugh-Berman, Co-Director of the M.S. HAPI program, commented on a new pain pill set for FDA review this January. The drug is non-opioid and aims to be an alternative to…
Advocacy in Action: PharmedOut Organizes a Letter Challenging “Dangerous Disinformation”
December 17th, 2024
A recent STAT news article covers Program Co-Director Dr. Adriane Fugh-Berman’s organization, PharmedOut, which has organized a letter signed by multiple experts on women’s health “demanding that…
Deceptive Pharma Surveys: New Op-Ed by Dr. Fugh-Berman and Judy Butler
December 16th, 2024
Program Co-Director Adriane Fugh-Berman and Judy Butler recently published an op-ed in the Pittsburgh Post-Gazette on the dangers of deceptively-worded, pharma-funded surveys. According to their…
